BDBM142030 US8927577, 11::US8927577, 30::US8927577, 31

SMILES CC(C)CC(Nc1nc2ccccc2cc1C)c1ccc(cc1)C(=O)NCCC(O)=O

InChI Key InChIKey=BVJDGKQCWAYVEZ-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 142030   

TargetPro-glucagon(Human)
Pfizer

US Patent
LigandPNGBDBM142030(US8927577, 31 | US8927577, 30 | US8927577, 11)
Affinity DataKi:  76nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2015
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Pfizer

US Patent
LigandPNGBDBM142030(US8927577, 31 | US8927577, 30 | US8927577, 11)
Affinity DataKi:  101nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2015
Entry Details
Go to US Patent

TargetPro-glucagon(Human)
Pfizer

US Patent
LigandPNGBDBM142030(US8927577, 31 | US8927577, 30 | US8927577, 11)
Affinity DataKi:  1.24E+3nMpH: 7.4Assay Description:The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2015
Entry Details
Go to US Patent